In gliomas 35 and cervical 36, pancreatic 37, and colorectal cancer 38, the overexpression of PHGDH is associated with advanced TNM stage, large tumor, higher tumor grade, and shorter overall survival time, respectively. This evidence concerns the gene PHGDH and central nervous system cancer.